Literature DB >> 446474

Cathepsin D of rat spleen. Affinity purification and properties of two types of cathepsin D.

K Yamamoto, N Katsuda, M Himeno, K Kato.   

Abstract

Two types of cathepsin D were purified from rat spleen by a rapid procedure involving an acid precipitation of tissue extract, affinity chromatography with pepstatin--Sepharose 4B and concanavalin-A--Sepharose 4B, and chromatography on Sephadex G-100 and DEAE-Sephacel. The purified major enzyme (85% of the cathepsin D activity after DEAE-Sephacel chromatography), termed cathepsin D-I, represented about a 1000-fold purification over the homogenate and about a 20% recovery. The purified minor enzyme (15%), termed cathepsin D-II, represented about a 900-fold purification and about a 3% recovery. Both enzymes showed four (pI: 4.2, 4.9, 6.1 and 6.5) and three (pI: 4.6, 5.6 and 5.8) multiple forms after isoelectric focusing, respectively. The purified enzymes appeared homogeneous on electrophoresis in polyacrylamide gel and had a molecular weight of about 44000. In sodium dodecylsulfate/polyacrylamide gel electrophoresis both enzymes showed a single protein band corresponding to a molecular weight of 44000. The enzymes had similar amino acid compositions except for serine, proline and methionine. Cathepsin D-I contained 6.6% carbohydrate, consisting of mannose, glucose, galactose, fucose and glucosamine in a ratio of 8:2:1:1:5 with a trace of sialic acid. The properties of purified enzymes were also compared.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 446474     DOI: 10.1111/j.1432-1033.1979.tb12985.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

1.  Role of LAMP-2 in lysosome biogenesis and autophagy.

Authors:  Eeva-Liisa Eskelinen; Anna Lena Illert; Yoshitaka Tanaka; Günter Schwarzmann; Judith Blanz; Kurt Von Figura; Paul Saftig
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

2.  Endocytic trafficking of megalin/RAP complexes: dissociation of the complexes in late endosomes.

Authors:  R P Czekay; R A Orlando; L Woodward; M Lundstrom; M G Farquhar
Journal:  Mol Biol Cell       Date:  1997-03       Impact factor: 4.138

3.  The production of small arterial lesions in nephrectomized rats by the administration of pure cathepsin D.

Authors:  M Kai-Yamamoto; H Kanaide; H Yamamoto; T Kurozumi; K Kato; M Nakamura
Journal:  Br J Exp Pathol       Date:  1982-10

4.  Cathepsins D and E in normal, metaplastic, dysplastic, and carcinomatous gastric tissue: an immunohistochemical study.

Authors:  T Saku; H Sakai; N Tsuda; H Okabe; Y Kato; K Yamamoto
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

5.  Conformation, structure and activation of bovine cathepsin D. Unfolding and refolding studies.

Authors:  T Lah; M Drobnic-Kosorok; V Turk; R H Pain
Journal:  Biochem J       Date:  1984-03-01       Impact factor: 3.857

6.  Proteomics identification of azaspiracid toxin biomarkers in blue mussels, Mytilus edulis.

Authors:  Judith K Nzoughet; John T G Hamilton; Catherine H Botting; Alastair Douglas; Lynda Devine; John Nelson; Christopher T Elliott
Journal:  Mol Cell Proteomics       Date:  2009-04-23       Impact factor: 5.911

7.  The pathogenesis of small arterial lesions in nephrectomized rats by the administration of renin.

Authors:  M Kai; H Kanaide; H Yamamoto; T Kurozumi; K Tanaka; M Nakamura
Journal:  Br J Exp Pathol       Date:  1981-04

8.  Cathepsin D as a vitality marker in human skin wounds.

Authors:  C Hernández-Cueto; J A Lorente; I Pedal; E Villanueva; G Zimmer; E Girela; E Miltner
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

9.  Biochemical assessment of acute myocardial ischaemia.

Authors:  M D Perez-Cárceles; E Osuna; D N Vieira; A Martínez; A Luna
Journal:  J Clin Pathol       Date:  1995-02       Impact factor: 3.411

10.  Cytochrome P-450 and NADPH-cytochrome P-450 reductase are degraded in the autolysosomes in rat liver.

Authors:  R Masaki; A Yamamoto; Y Tashiro
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.